Search Results - "MEKO, J. B"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    MANAGEMENT OF PATIENTS WITH ZOLLINGER-ELLISON SYNDROME by Meko, M.D, J. B, Norton, M.D, J. A

    Published in Annual review of medicine (01-01-1995)
    “…Zollinger-Ellison syndrome (ZES) is caused by gastrin-secreting tumors called gastrinomas. Patients commonly present with peptic ulcer disease and may have…”
    Get full text
    Journal Article
  2. 2

    Large cystic/solid thyroid nodules: A potential false-negative fine-needle aspiration by Meko, Jennifer B., Norton, Jeffrey A.

    Published in Surgery (01-12-1995)
    “…Background. False-negative fine-needle aspiration (FNA) biopsy results of thyroid nodules are of particular concern because they imply missed malignant…”
    Get full text
    Journal Article
  3. 3

    Evaluation of somatostatin-receptor scintigraphy for detecting neuroendocrine tumors by Meko, Jennifer B., Doherty, Gerard M., Siegel, Barry A., Norton, Jeffrey A.

    Published in Surgery (01-12-1996)
    “…Background. Somatostatin-receptor scintigraphy (SRS) has gained attention as an imaging modality for neuroendocrine tumors (NETs). The purpose of this study…”
    Get full text
    Journal Article
  4. 4

    High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12 by MEKO, J. B, YIM, J. H, KANGLA TSUNG, NORTON, J. A

    Published in Cancer research (Chicago, Ill.) (01-11-1995)
    “…We have constructed a recombinant vaccinia virus (recVV), vKT0334 mIL-12, containing the genes encoding the p35 and p40 subunits of murine interleukin-12…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Cytokine production and antitumor effect of a nonreplicating, noncytopathic recombinant vaccinia virus expressing interleukin-12 by Meko, Jennifer B., Tsung, Kangla, Norton, Jeffrey A.

    Published in Surgery (01-08-1996)
    “…Background. Cancer gene therapy with interleukin-12 (IL-12) has generated much interest because of the potent antitumor effects of this cytokine. The purpose…”
    Get full text
    Journal Article
  7. 7

    IL-12 induces T helper 1-directed antitumor response by Tsung, K, Meko, JB, Peplinski, GR, Tsung, YL, Norton, JA

    Published in The Journal of immunology (1950) (01-04-1997)
    “…Although IL-12 possesses the most potent single-cytokine antitumor efficacy, the mechanism by which IL-12 exerts its antitumor activities remains unclear…”
    Get full text
    Journal Article
  8. 8

    Immune Response Against Large Tumors Eradicated by Treatment with Cyclophosphamide and IL-12 by Tsung, Kangla, Meko, Jennifer B, Tsung, Ying L, Peplinski, Gary R, Norton, Jeffrey A

    Published in The Journal of immunology (1950) (01-02-1998)
    “…Previous studies have demonstrated eradication of small (4-8 mm) established murine MCA207 sarcomas by treatment with systemic IL-12. Analysis of the mechanism…”
    Get full text
    Journal Article
  9. 9

    Endocrine tumors of the pancreas by Meko, J B, Norton, J A

    “…Pancreatic endocrine tumors are rare, yet can cause significant morbidity due to excessive secretion of hormones. Octreotide is effective in reducing the…”
    Get more information
    Journal Article
  10. 10

    Prevention of murine breast cancer by vaccination with tumor cells modified by cytokine-producing recombinant vaccinia viruses by Peplinski, G R, Tsung, K, Meko, J B, Norton, J A

    Published in Annals of surgical oncology (01-01-1996)
    “…Cancer gene therapy expressing specific levels of multiple genes has not been adequately tested. This study investigates the antitumor effects of recombinant…”
    Get full text
    Journal Article
  11. 11

    Induction of antigen-presenting capacity in tumor cells upon infection with non-replicating recombinant vaccinia virus encoding murine MHC class II and costimulatory molecules by Marti, Walter R., Oertli, Daniel, Meko, Jennifer B., Norton, Jeffrey A., Tsung, Kangla

    Published in Journal of immunological methods (15-01-1997)
    “…The possibility of inducing antigen-presenting capacity in cells normally lacking such capacity, currently represents a major goal in vaccine research. To…”
    Get full text
    Journal Article
  12. 12

    Construction and expression in tumor cells of a recombinant vaccinia virus encoding human interleukin-1 beta by Peplinski, G R, Tsung, K, Whitman, E D, Meko, J B, Norton, J A

    Published in Annals of surgical oncology (01-03-1995)
    “…Human interleukin-1 beta (hIL-1 beta) injected intratumorally has demonstrated growth inhibition of transplanted subcutaneous tumors in mice, regression of…”
    Get full text
    Journal Article
  13. 13

    In vivo gene therapy of a murine pancreas tumor with recombinant vaccinia virus encoding human interleukin-1 beta by Peplinski, G R, Tsung, K, Meko, J B, Norton, J A

    Published in Surgery (01-08-1995)
    “…Recombinant vaccinia virus (VV) encoding human interleukin-1 beta (vMJ601hIL-1 beta) given intravenously persists in tumor tissue and expresses hIL-1 beta for…”
    Get full text
    Journal Article
  14. 14
  15. 15

    In vivo gene therapy of a murine pancreas tumor with recombinant vaccinia virus encoding human interleukin-1beta by Peplinski, Gary R., Tsung, Kangla, Meko, Jennifer B., Norton, Jeffrey A.

    Published in Surgery (01-08-1995)
    “…Background. Recombinant vaccinia virus (VV) encoding human interleukin-1β (vMJ601hIL-1β) given intravenously persists in tumor tissue and expresses hIL-1β for…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    In vivo murine tumor gene delivery and expression by systemic recombinant vaccinia virus encoding interleukin-1beta by Peplinski, G R, Tsung, A K, Casey, M J, Meko, J B, Fredrickson, T N, Buller, R M, Norton, J A

    “…This study investigates the feasibility of systemic gene delivery in a tumor-bearing host using a vaccinia virus-based in vivo gene delivery and expression…”
    Get more information
    Journal Article